皮佩拉西林/塔扎巴克坦用于胰腺切除术期间的外科预防:元分析
Jayant Kumar1,2, Isabella Reccia3, Adriano Carneiro4
1Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK.
BJS open
|June 13, 2024
概括
与传统抗生素相比,piperacillin/tazobactam显著减少了手术部位感染和胰腺切除术后的并发症. 这一发现支持其用于手术预防,以改善患者的治疗结果.
科学领域:
- 手术瘤学手术瘤学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 胰腺二管切除术带有手术部位感染 (SSI) 的高风险,增加了患者的发病率和死亡率.
- 传统的抗生素预防策略往往不足以预防SSI在这种高风险的程序.
研究的目的:
- 为了比较皮佩拉西林/塔扎巴克坦与传统抗生素在接受胰腺切除术的患者中进行抗菌预防的疗效.
- 评估对手术部位感染,重大手术并发症,胰腺抽和死亡率的影响.
主要方法:
- 进行了系统的元分析,搜索了2000年至2023年间发表的研究的数据库.
- 包括的研究包括前性/后性队列和RCT,数据使用RevMan 5.4.4进行分析.
- 这项分析涉及2382名患者,比较了piperacillin/tazobactam (1196名患者) 与传统抗生素 (1186名患者).
主要成果:
- 皮佩拉西林/塔扎巴克坦显著减少了整体SSI (OR 0.43) 和主要手术并发症 (OR 0.61).
- 亚组分析显示,皮佩拉西林/塔扎巴克坦减少了表面SSI (OR0.34) 和器官/空间SSI (OR0.47).
- 此组还经历了显著较低的胰腺抽率 (OR 0.67) 和死亡率 (OR 0.51).
结论:
- 皮佩拉西林/塔扎巴克坦是一种优质的抗菌预防剂,用于胰腺切除术.
- 它有效降低了SSI,主要并发症,胰腺囊和死亡率的风险.
- 在目前的实践中,建议在手术预防中使用皮佩拉西林/塔扎巴克坦.
相关概念视频
01:30Acute Pancreatitis II: Clinical Manifestations and Management
118
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
118
01:29Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84